Lacosamide
- Product NDC
- 65162-925
- 11-digit product format
- 651620925
- Labeler code
- 65162
- Product ID
- 65162-925_4f62fcbd-17ca-4664-9215-da51ba027b22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lacosamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA204857
- Marketing category
- ANDA
- Marketing start
- 2022-03-21
- Marketing end
- 0000-00-00
- Substance
- LACOSAMIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-925 | LACOSAMIDE TABLET [AMNEAL PHARMACEUTICALS LLC] | 32 | Legacy NDC | 20240215_70782d6e-9dd1-400c-bd3e-511cdb26e24a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-925-06 | 65162092506 | 60 TABLET in 1 BOTTLE (65162-925-06) | 60 tablet | 2022-03-21 | 0000-00-00 | No | No | Current |
| 65162-925-50 | 65162092550 | 500 TABLET in 1 BOTTLE (65162-925-50) | 500 tablet | 2022-03-21 | 0000-00-00 | No | No | Current |